Bill Text: OH SB230 | 2013-2014 | 130th General Assembly | Engrossed

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: To change the requirements to serve as the Executive Director of the State Board of Pharmacy and to establish standards for the delivery of non-self-injectable cancer drugs.

Spectrum: Slight Partisan Bill (Republican 18-11)

Status: (Passed) 2014-09-17 - Effective Date [SB230 Detail]

Download: Ohio-2013-SB230-Engrossed.html

---

As Passed by the Senate

130th General Assembly Regular Session 2013-2014

S. B. No. 230

Senators Manning, Oelslager 

Cosponsors: Senators Jones, Lehner, Patton, Cafaro, Brown, Tavares, Eklund, LaRose, Schiavoni, Seitz, Skindell, Turner 

---

A BILL

To enact section 4729.43 of the Revised Code to

1

establish standards for the delivery of

2

non-self-injectable cancer drugs.

3

BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF OHIO:

Section 1. That section 4729.43 of the Revised Code be	4
enacted to read as follows:	5

Sec. 4729.43. (A) As used in this section:

6

(1) "Home health agency" has the same meaning as in section	7
3701.881 of the Revised Code.	8

(2) "Hospice care program" and "hospice patient" have the	9
same meanings as in section 3712.01 of the Revised Code.	10

(B) With regard to a dangerous drug that is indicated for the	11
treatment of cancer or a cancer-related illness, must be	12
administered intravenously or by subcutaneous injection, and	13
cannot reasonably be self-administered by the patient to whom the	14
drug is prescribed or by an individual assisting the patient with	15
the self-administration, a pharmacist or pharmacy intern shall not	16
dispense the drug by delivering the drug directly to any of the	17
following or causing the drug to be delivered directly to any of	18
the following:	19

(1) The patient;

20

(2) The patient's representative, which may include the	21
patient's guardian or a family member or friend of the patient;	22

(3) The patient's private residence unless any of the	23
following is the case:	24

(a) The patient's private residence is a nursing home,	25
residential care facility, rehabilitation facility, or similar	26
institutional facility or heath care facility.	27

(b) If the patient is an adult and a hospice patient or	28
client of a home health agency, the patient, the licensed health	29
professional authorized to prescribe drugs who prescribed the drug	30
to the patient, or an employee or agent of the prescriber has	31
notified the pharmacist or pharmacy intern that the patient is a	32
hospice patient or client of a home health agency and an employee	33
or agent of the hospice care program or home health agency will be	34
administering the drug to the patient.	35

(c) If the patient is a minor and a hospice patient or client	36
of a home health agency, either of the following has notified the	37
pharmacist or pharmacy intern that the patient is a client of a	38
home health agency and an employee or agent of the hospice care	39
program or home health agency will be administering the drug to	40
the patient:	41

(i) The licensed health professional authorized to prescribe	42
drugs who prescribed the drug to the patient or an employee or	43
agent of the prescriber;	44

(ii) The parent, guardian, or other person who has care or	45
charge of the patient and is authorized to consent to medical	46
treatment on behalf of the patient.	47